Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | SVP, Research & Development | July 28, 2024 | July 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date July 28, 2024 · Filed July 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,357 |
Ending reported balance
After 2024-07-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-07-28 · Grant · Acquired 1,170 · Balance 36,951 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2024-07-28 · Tax withholding · Disposed 594 · Balance 36,357 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-07-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-07-28 · Exercise / conversion · Disposed 1,170 · Balance 0 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-05-27 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-05-27 · Grant · Acquired 4,376 · Balance 20,932 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2022-05-27 · Tax withholding · Disposed 2,170 · Balance 18,762 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Row 3 · 2022-05-27 · Disposition to issuer · Disposed 18,762 · Balance 0 F3: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Exercise / conversion · Disposed 4,376 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F5: Vested in full. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 3,925 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9: 3,925 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 2,743 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 823 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 4,268 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 4,268 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 1,962 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-27 · Disposition to issuer · Disposed 2,625 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-27 · Disposition to issuer · Disposed 3,510 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-05-27 · Disposition to issuer · Disposed 10,642 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2022-05-27 · Disposition to issuer · Disposed 7,256 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 2,303 · Balance 0 F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 3,924 · Balance 0 F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F4: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F5: Vested in full.
F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F7: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023.
F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F9: 3,925 shares will vest on February 4, 2023.
F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F11: 4,268 shares will vest on February 4, 2023.
F12: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.
F13: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.
F14: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.
F15: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.
F16: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 03, 2019 Filed Dec 5, 2019 21:35 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 12,974 | $68.02 | $882,477.21 |
DisclosureSEC source: 0001209191-19-059404 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,795 F4 · price: The weighted average sale price for these transactions was $66.018852 per share, with a range of $67.95 to $68.12. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:35 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 6,620 | $68.01 | $450,229.51 |
DisclosureSEC source: 0001209191-19-059404 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,769 F3 · price: The weighted average sale price for these transactions was $68.010509 per share, with a range of $67.95 to $68.12. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:35 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 6,620 | $22.85 | $151,267.00 |
DisclosureSEC source: 0001209191-19-059404 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:35 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 3,357 | $68.03 | $228,371.67 |
DisclosureSEC source: 0001209191-19-059404 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,769 F1 · price: The weighted average sale price for these transactions was $68.028508 per share, with a range of $67.95 to $68.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. F2 · balance_after: The amount of securities beneficially owned following this transaction include an additional 357 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 27, 2019 Filed May 29, 2019 18:50 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,170 | $54.42 | $118,091.40 |
DisclosureSEC source: 0001209191-19-033287 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,769 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 27, 2019 Filed May 29, 2019 18:50 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 4,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033287 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,939 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 20:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Premium) · Derivative | 823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009918 · doc4.xml · derivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823 Underlying: Common Stock · 823 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest on the first anniversary date of the grant date, February 11, 2020. F3 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2018 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 20:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Converted) · Derivative | 2,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009918 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,743 Underlying: Common Stock · 2,743 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on the date of the grant, February 11, 2019. F3 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2018 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document |
| February 10, 2019 Filed Feb 12, 2019 20:39 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 424 | $58.37 | $24,748.88 |
DisclosureSEC source: 0001209191-19-009527 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,562 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 10, 2019 Filed Feb 12, 2019 20:39 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 1,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009527 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,986 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 21:24 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 490 | $59.00 | $28,910.00 |
DisclosureSEC source: 0001209191-19-007938 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,785 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. F3 · balance_after: The amount of securities beneficially owned following this transaction include an additional 69 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 21:24 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 1,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007938 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,206 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:24 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 3,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007938 · doc4.xml · derivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,925 Underlying: Common Stock · 3,925 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F6 · derivative.exercise_date: 3,925 shares will vest on the fourth anniversary date of the grant date, February 4, 2023. F6 · derivative.expiration_date: 3,925 shares will vest on the fourth anniversary date of the grant date, February 4, 2023. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:24 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantNon-Qualified Stock Option · Derivative | 7,850 | $0.00 Strike: $59.12 | $0.00 |
DisclosureSEC source: 0001209191-19-007938 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,850 Underlying: Common Stock · 7,850 shares Expires 2029-02-04 F4 · derivative.exercise_date: 3,925 shares will vest on the second anniversary date of the grant date, February 4, 2021. 1,963 shares will vest on the third anniversary date of the grant date, February 4, 2022. 1,962 shares will vest on the fourth anniversary date of the grant date, February 4, 2023. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 20:00 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 2,500 | $66.16 | $165,392.00 |
DisclosureSEC source: 0001209191-18-037605 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,005 F1 · price: The weighted average sale price for these transactions was $66.1568 per share, with a range of $66.15 to $66.18. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 27, 2018 Filed May 30, 2018 20:13 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 3,783 | $61.20 | $231,519.60 |
DisclosureSEC source: 0001209191-18-034287 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,505 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 27, 2018 Filed May 30, 2018 20:13 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 10,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034287 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,288 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:30 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,479 | $45.10 | $111,802.90 |
DisclosureSEC source: 0001209191-18-011686 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,348 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:30 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 7,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011686 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,827 F1 · shares: Reporting Person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 2/15/2017. F2 · balance_after: The amount of securities beneficially owned prior to this transaction included an additional 664 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 10, 2018 Filed Feb 13, 2018 20:12 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 840 | $42.94 | $36,069.60 |
DisclosureSEC source: 0001209191-18-009822 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,992 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 10, 2018 Filed Feb 13, 2018 20:12 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 2,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-009822 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,832 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:21 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 490 | $43.58 | $21,354.20 |
DisclosureSEC source: 0001209191-18-008286 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,429 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:21 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 1,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008286 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,919 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:06 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 2,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006331 · doc4.xml · derivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,970 Underlying: Common Stock · 2,970 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F2 · derivative.exercise_date: 2,970 shares will vest on the third anniversary date of the grant date, January 29, 2021. F2 · derivative.expiration_date: 2,970 shares will vest on the third anniversary date of the grant date, January 29, 2021. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:06 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantNon-Qualified Stock Option · Derivative | 2,970 | $0.00 Strike: $47.85 | $0.00 |
DisclosureSEC source: 0001209191-18-006331 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,970 Underlying: Common Stock · 2,970 shares Expires 2028-01-29 Read SEC document |
| January 16, 2018 Filed Jan 23, 2018 17:30 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 4,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-004959 · doc4.xml · derivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,606 Underlying: Common Stock · 4,606 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F3 · derivative.exercise_date: 4,606 shares will vest on the fourth anniversary date of the grant date, January 16, 2022. F3 · derivative.expiration_date: 4,606 shares will vest on the fourth anniversary date of the grant date, January 16, 2022. Read SEC document |
| January 16, 2018 Filed Jan 23, 2018 17:30 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantNon-Qualified Stock Option · Derivative | 9,212 | $0.00 Strike: $46.41 | $0.00 |
DisclosureSEC source: 0001209191-18-004959 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,212 Underlying: Common Stock · 9,212 shares Expires 2028-01-16 F1 · derivative.exercise_date: 4,606 shares will vest on the second anniversary date of the grant date, January 16, 2020. 2,303 shares will vest on the third anniversary date of the grant date, January 16, 2021. 2,303 shares will vest on the fourth anniversary date of the grant date, January 16, 2022. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 20:14 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Option · Derivative | 9,258 | $0.00 Strike: $23.41 | $0.00 |
DisclosureSEC source: 0001209191-17-065297 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,596 Underlying: Common Stock · 9,258 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 20:14 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Option · Derivative | 7,100 | $0.00 Strike: $23.41 | $0.00 |
DisclosureSEC source: 0001209191-17-065297 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,854 Underlying: Common Stock · 7,100 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 20:14 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 9,258 | $40.41 | $374,081.53 |
DisclosureSEC source: 0001209191-17-065297 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 F2 · price: The weighted average sale price for these transactions was $40.406319 per share, with a range of $40.36 to $40.45. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 20:14 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 9,258 | $23.41 | $216,729.78 |
DisclosureSEC source: 0001209191-17-065297 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 20:14 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 7,100 | $40.49 | $287,447.76 |
DisclosureSEC source: 0001209191-17-065297 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 F1 · price: The weighted average sale price for these transactions was $40.485564 per share, with a range of $40.40 to $40.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 20:14 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 7,100 | $23.41 | $166,211.00 |
DisclosureSEC source: 0001209191-17-065297 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Option · Derivative | 1,238 | $0.00 Strike: $23.41 | $0.00 |
DisclosureSEC source: 0001209191-17-064568 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,954 Underlying: Common Stock · 1,238 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 17,596 shares vested on 02/05/2017; 8,798 shares will vest on 02/05/2018; and 8,798 shares will vest on 02/05/2019. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Option · Derivative | 12,298 | $0.00 Strike: $22.85 | $0.00 |
DisclosureSEC source: 0001209191-17-064568 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,620 Underlying: Common Stock · 12,298 shares Expires 2024-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 13,242 shares vested on 05/27/2016; 6,621 shares vested on 05/27/2017; and 6,620 shares will vest on 05/27/2018. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 1,238 | $40.51 | $50,151.38 |
DisclosureSEC source: 0001209191-17-064568 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 1,238 | $23.41 | $28,981.58 |
DisclosureSEC source: 0001209191-17-064568 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 12,298 | $40.51 | $498,191.98 |
DisclosureSEC source: 0001209191-17-064568 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 20:05 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 12,298 | $22.85 | $281,009.30 |
DisclosureSEC source: 0001209191-17-064568 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 20:27 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Option · Derivative | 7,565 | $0.00 Strike: $22.85 | $0.00 |
DisclosureSEC source: 0001209191-17-059864 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,918 Underlying: Common Stock · 7,565 shares Expires 2024-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 13,242 shares vested on the second anniversary date of the grant date, May 27, 2016. 6,621 shares vested on the third anniversary date of the grant date, May 27, 2017. 6,620 shares will vest on the fourth anniversary date of the grant date, May 27, 2018. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 20:27 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 7,565 | $39.50 | $298,817.50 |
DisclosureSEC source: 0001209191-17-059864 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 F1 · balance_after: The amount of securities beneficially owned following this transaction include an additional 1,022 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 20:27 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 7,565 | $22.85 | $172,860.25 |
DisclosureSEC source: 0001209191-17-059864 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2017 Filed Feb 17, 2017 20:55 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Premium) · Derivative | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012418 · doc4.xml · derivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055 Underlying: Common Stock · 1,055 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F6 · derivative.exercise_date: The restricted stock units vest on the first anniversary date of the grant date, February 17, 2018. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting persons 2016 cash bonus pursuant to the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document |
| February 17, 2017 Filed Feb 17, 2017 20:55 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Converted) · Derivative | 3,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012418 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,519 Underlying: Common Stock · 3,519 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest on the date of grant, February 17, 2017. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting persons 2016 cash bonus pursuant to the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:55 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 7,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012418 · doc4.xml · derivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,172 Underlying: Common Stock · 7,172 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F3 · derivative.exercise_date: 7,172 shares will vest on the fourth anniversary date of the grant date, February 15, 2021. F3 · derivative.expiration_date: 7,172 shares will vest on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:55 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantNon-Qualified Stock Options · Derivative | 14,343 | $0.00 Strike: $21.08 | $0.00 |
DisclosureSEC source: 0001209191-17-012418 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,343 Underlying: Common Stock · 14,343 shares Expires 2027-02-15 F1 · derivative.exercise_date: 7,172 shares will vest on the second anniversary date of the grant date, February 15, 2019. 3,586 shares will vest on the third anniversary date of the grant date, February 15, 2020. 3,585 shares will vest on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document |
| February 05, 2017 Filed Feb 8, 2017 21:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 1,052 | $19.15 | $20,145.80 |
DisclosureSEC source: 0001209191-17-008951 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,696 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 05, 2017 Filed Feb 8, 2017 21:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 2,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008951 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,748 F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4. F2 · balance_after: The amount of securities beneficially owned following this transaction include an additional 1,345 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.